Daewoong Bio file appeal, “GLIATAMIN and GLIATILIN has no similarity in trademark”
Daewoong Bio said on the 30th “Cognition-enhancing GLIATAMIN and Italfarmaco’s GLIATILIN have no similarity in appearance, name and concept. We’ll immediately file an appeal.”
It was the company’s official position about the lost case on the GLIATAMIN trademark nullification trial, recently rule...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.